HC Wainwright Has Pessimistic View of Senestech Q2 Earnings

Posted by Francis Steltz on May 19th, 2026

Senestech, Inc. (NASDAQ:SNES – Free Report) – Research analysts at HC Wainwright lowered their Q2 2026 EPS estimates for Senestech in a research report issued to clients and investors on Friday, May 15th. HC Wainwright analyst A. Dayal now forecasts that the company will post earnings per share of ($0.40) for the quarter, down from their previous estimate of ($0.34). The consensus estimate for Senestech’s current full-year earnings is ($1.36) per share. HC Wainwright also issued estimates for Senestech’s Q3 2026 earnings at ($0.41) EPS, Q4 2026 earnings at ($0.41) EPS, FY2026 earnings at ($1.61) EPS, FY2027 earnings at ($1.43) EPS, FY2028 earnings at ($0.67) EPS and FY2029 earnings at $0.10 EPS.

Senestech (NASDAQ:SNES – Get Free Report) last posted its earnings results on Tuesday, May 12th. The company reported ($0.31) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.02. The company had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.63 million. Senestech had a negative net margin of 304.22% and a negative return on equity of 67.60%.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Senestech in a research report on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Senestech currently has an average rating of “Hold”.

View Our Latest Stock Report on Senestech

Senestech Trading Down 1.9%

SNES opened at $1.59 on Tuesday. The firm’s fifty day moving average is $1.70 and its two-hundred day moving average is $2.16. The company has a debt-to-equity ratio of 0.02, a quick ratio of 7.79 and a current ratio of 8.91. The firm has a market cap of $8.43 million, a PE ratio of -0.84 and a beta of 0.18. Senestech has a twelve month low of $1.41 and a twelve month high of $6.24.

Insider Activity

In other news, major shareholder Glenbrook Capital Management acquired 146,249 shares of the firm’s stock in a transaction that occurred on Friday, March 13th. The stock was acquired at an average cost of $1.95 per share, for a total transaction of $285,185.55. Following the completion of the acquisition, the insider owned 865,850 shares in the company, valued at $1,688,407.50. This represents a 20.32% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders bought 254,248 shares of company stock worth $499,846 in the last ninety days. 2.20% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Diversify Wealth Management LLC bought a new position in shares of Senestech during the first quarter worth about $31,000. Jane Street Group LLC bought a new position in Senestech in the fourth quarter valued at $32,000. Diversify Advisory Services LLC bought a new position in Senestech in the fourth quarter valued at $34,000. XTX Topco Ltd bought a new position in Senestech in the fourth quarter valued at $54,000. Finally, Geode Capital Management LLC bought a new position in Senestech in the second quarter valued at $59,000. 5.19% of the stock is currently owned by institutional investors.

About Senestech

(Get Free Report)

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.